We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

CORMAY

Cormay develops and manufactures diagnostic reagents and laboratory equipment, including hematology analyzers and cli... read more Featured Products: More products

Download Mobile App





Cormay Diagnostics Introduces True 5+ DIFF Multi-Patented Hematology Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022

Cormay Diagnostics (Warsaw, Poland) is participating in this year’s edition of MEDICA, where the company is presenting its range of high quality diagnostic reagents and advanced laboratory analyzers. More...

At MEDICA 2022, Cormay is showcasing the MYTHIC 70, a true 5+DIFF hematology analyzer that delivers 29 parameters in less than 60 seconds. Its superior technology ensures reliability and multi-patented solution with unmatchable cost savings. It features walk away function and allows loading of 50 samples for improving laboratory efficiency. Alongside the MYTHIC 70, Cormay is exhibiting the MYTHIC 3CRP, a 3 DIFF hematology analyzer that offers a two-in-one solution. The MYTHIC 3CRP analyzer is designed to analyze whole blood samples, including measurement of blood cell count, hemoglobin concentration, CRP concentration and 3-part leukocytes differentiation.

In addition to its range of hematology analyzers, Cormay is also highlighting its portfolio of chemistry analyzers, including the ACCENT M320 and ACCENT S120. The ACCENT M320 and ACCENT S120 are computer-controlled, fully-automated chemistry analyzers for in-vitro diagnostic use in clinical laboratories to measure activity or concentration of clinical chemistry parameters in serum, plasma, urine and cerebrospinal fluid samples. Together with the highest quality dedicated reagent line, calibrators and controls, they provide a complete solution suitable for small to mid-size laboratories.

Among its urine analyzers being showcased by Cormay at MEDICA 2022 are the Uri-Tex and URI-TEX 300 semi-automatic urine chemistry analyzers. Designed to be used with Cormay urinalysis strips, the intelligent Uri-Tex image analyzer locates the strip and the pads, reads the color data, and based on these, determines the parameter values. Its intuitive device operation makes analysis easy and allows for fast determination of multiple chemical compounds in urine. Similarly, the Uri-Tex 300 semiautomatic urine chemistry analyzer is also designed to be used with Cormay urinalysis strips and determines the multiple parameters values in urine in less than a minute. The operator is only required to dip the strips into the samples and place them on the strips loading plate which allows for a maximum of 10 strips to be loaded at one time.

Related Links:
Cormay Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hematology Consumables
Bioblood Devices
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.